diazoxide has been researched along with Bartholin-Patau Syndrome in 2 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneyasu, H | 1 |
| Okada, S | 1 |
| Takahashi, K | 1 |
| Hasegawa, S | 1 |
| Nagaoka, M | 1 |
| Akaishi, M | 1 |
| Iida, K | 1 |
| Yoshida, T | 1 |
2 other studies available for diazoxide and Bartholin-Patau Syndrome
| Article | Year |
|---|---|
Successful use of trichlormethiazide for diazoxide-related water retention in an infant with trisomy 13.
Topics: Body Water; Diazoxide; Humans; Infant; Treatment Outcome; Trichlormethiazide; Trisomy 13 Syndrome | 2023 |
Diazoxide toxicity with hypoglycemia in infants with trisomy 13.
Topics: Blood Glucose; Diazoxide; Humans; Hypoglycemia; Infant; Trisomy 13 Syndrome | 2021 |